- New CDER appointment elevates longtime GLP-1 reviewerActing FDA CDER director Michael Davis has promoted a longtime FDA staffer as an acting deputy director at the drug center. Lisa Yanoff, an agency veteran with expertise in metabolic drug revie…Endpoints · 20d ago↗ source
- STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversightA new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical care.STAT · 20d ago↗ source
- Bristol Myers details Krazati confirmatory study failure in colorectal cancerWhile Americans geared up for the July 4 holiday, Bristol Myers Squibb laid out how a confirmatory trial for its drug Krazati failed in colorectal cancer. Patients taking Krazati plus another dru…